Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cilo Cybin HoldingsJSE:CCC 2 Days Payable is 78.50 as of Sep. 2025, which is 5985% above its 10-year median of 1.29. GuruFocus rates JSE:CCC with a GF Score™ of 2/100. The stock has 5 warning signs investors should review. Among 928 Drug Manufacturers companies, Cilo Cybin Holdings ranks worse than 95.15% on this metric.
The historical rank and industry rank for Cilo Cybin Holdings's Days Payable or its related term are showing as below:
JSE:CCC'
s Days Payable Range Over the Past 10 Years
Min: 0.3 Med: 1.29 Max: 20.8
Current: 20.8
During the past 3 years, Cilo Cybin Holdings's highest Days Payable was 20.80. The lowest was 0.30. And the median was 1.29.
JSE:CCC's Days Payable is ranked worse than 95.15% of 928
companies
in the Drug Manufacturers industry
Industry Median: 88.385
vs JSE:CCC: 20.80
Cilo Cybin Holdings's Days Payable
increased
from Sep. 2024 (0.00) to Sep. 2025 (78.50).
It may suggest that Cilo Cybin Holdingsdelayed paying its suppliers.
The historical data trend for Cilo Cybin Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cilo Cybin Holdings Days Payable Chart
Cilo Cybin Holdings Annual Data
Trend
Mar23
Mar24
Mar25
Days Payable
0.00
0.30
2.28
Cilo Cybin Holdings Semi-Annual Data
Sep24
Mar25
Sep25
Days Payable
0.00
0.00
78.50
JSE:CCC vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cilo Cybin Holdings Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Cilo Cybin Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cilo Cybin Holdings's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cilo Cybin Holdings (JSE:CCC) has a Days Payable of 78.50 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cilo Cybin Holdings and its competitors. This is 5985% above median its historical median of 1.29. Over the past decade, Cilo Cybin Holdings' Days Payable has ranged from 0.30 to 20.80. According to the industry distribution chart, Cilo Cybin Holdings ranks #883 out of 928 companies in the Drug Manufacturers industry, placing it in the top 95.2%.
Is Cilo Cybin Holdings' Days Payable too high?
Cilo Cybin Holdings' current Days Payable of 78.50 is 5985% above median its 10-year median of 1.29. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 20.80. The Drug Manufacturers industry median Days Payable is 88.39. Cilo Cybin Holdings' value of 78.50 is 11.2% below this industry median. Based on the distribution chart, Cilo Cybin Holdings ranks #883 out of 928 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cilo Cybin Holdings has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Cilo Cybin Holdings' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cilo Cybin Holdings ranks #883 out of 928 companies for Days Payable. This places Cilo Cybin Holdings in the lower half of its industry. The industry median Days Payable is 88.39. Cilo Cybin Holdings' value of 78.50 is 11.2% below this benchmark. Historically, Cilo Cybin Holdings' own Days Payable has ranged from 0.30 to 20.80 over the past decade. While the company's 10-year median is 1.29 vs. the industry median of 88.39, Cilo Cybin Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.39, based on 928 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cilo Cybin Holdings's current Days Payable of 78.50 is 11.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cilo Cybin Holdings and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cilo Cybin Holdings's current Days Payable is 78.50, which is 5985% above median its own 10-year median of 1.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cilo Cybin Holdings stock overvalued right now?
Cilo Cybin Holdings (JSE:CCC) has a current Days Payable of 78.50. The current Days Payable is 78.50, which is 5985% above median its 10-year median of 1.29 and 11.2% below the Drug Manufacturers industry median of 88.39. Cilo Cybin Holdings' overall GF Score™ is 2/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cilo Cybin Holdings (JSE:CCC), the current Days Payable is 78.50 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cilo Cybin Holdings Ltd is engaged in identifying viable investments in Biotech, Biohacking and Pharmaceutical businesses. It offers products and services in the medical cannabis sector.
2GF Score
Get the complete analysis for JSE:CCC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:CCC has been successfully added to your 
